To define the NOD-mediated signaling pathway that is associated with Groα treatment, the gene and protein expressions of NOD1, NOD2 and RIPK2 in two types of HNSCC cells that had been treated with Groα for 72 h were obtained by RT-PCR and western blot analysis. The gene discussed is RIPK2; the disease is head and neck squamous cell carcinoma.